Cognitive changes in topiramate-treated patients with alcoholism: A 12-week prospective study in patients recently detoxified

Psychiatry and Clinical Neurosciences

Volumn 66, Issue 3, 2012, Pages 235-241

  Likhitsathian, Surinporn ^a   Saengcharnchai, Pichai ^c   Uttawichai, Kanok ^b   Yingwiwattanapong, Jatsada ^c   Wittayanookulluk, Apisak ^a   Srisurapanont, Manit ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b Chiang Mai Drug Dependence Treatment Center   (Thailand)

^c PHRAMONGKUTKLAO HOSPITAL   (Thailand)

Author keywords

alcoholism; cognitive function; detoxification; Montreal Cognitive Assessment; topiramate

Indexed keywords

TOPIRAMATE;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DETOXIFICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DOSE ESCALATION; DRUG WITHDRAWAL; FEMALE; HOSPITAL PATIENT; HUMAN; LANGUAGE TEST; MALE; MILD COGNITIVE IMPAIRMENT; PARTICIPANT OBSERVATION; PATIENT ASSESSMENT; PROSPECTIVE STUDY; RECALL;

ADOLESCENT; ADULT; ALCOHOLIC INTOXICATION; ALCOHOLISM; COGNITION; COGNITION DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; NEUROPSYCHOLOGICAL TESTS; PATIENT DROPOUTS; PROSPECTIVE STUDIES; PSYCHOMOTOR PERFORMANCE; RECOVERY OF FUNCTION; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859089833     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2012.02326.x     Document Type: Article

References (26)

1. Moghaddam B, Bolinao ML,. Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: Implications for tonic influence of glutamate on dopamine release. Synapse 1994; 18: 337-342. (Pubitemid 24357833)
2. Skradski S, White HS,. Topiramate blocks kainate-evoked cobalt influx into cultured neurons. Epilepsia 2000; 41 (Suppl.): S45-S47.
3. Johnson BA, Ait-Daoud N, Bowden CL, et al,. Oral topiramate for treatment of alcohol dependence: A randomised controlled trial. Lancet 2003; 361: 1677-1685. (Pubitemid 36577440)
4. Johnson BA, Rosenthal N, Capece JA, et al,. Topiramate for treating alcohol dependence: A randomized controlled trial. JAMA 2007; 298: 1641-1651. (Pubitemid 47606653)
5. Baltieri DA, Daro FR, Ribeiro PL, de Andrade AG,. Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 2008; 103: 2035-2044.
6. Wheeler SD,. Donepezil treatment of topiramate-related cognitive dysfunction. Headache 2006; 46: 332-335.
7. Crawford P,. An audit of topiramate use in a general neurology clinic. Seizure 1998; 7: 207-211. (Pubitemid 28344886)
8. Lee HW, Jung DK, Suh CK, Kwon SH, Park SP,. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up. Epilepsy Behav. 2006; 8: 736-741.
9. Romigi A, Cervellino A, Marciani MG, et al,. Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: An open study. Eur. J. Neurol. 2008; 15: 190-195.
10. Meador KJ, Loring DW, Vahle VJ, et al,. Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology 2005; 64: 2108-2114. (Pubitemid 40881003)
11. Brandt J, Butters N, Ryan C, Bayog R,. Cognitive loss and recovery in long-term alcohol abusers. Arch. Gen. Psychiatry 1983; 40: 435-442. (Pubitemid 13118578)
12. Grant I, Adams K, Reed R,. Aging, abstinence, and medical risk factors in the prediction of neuropsychologic deficit among long-term alcoholics. Arch. Gen. Psychiatry 1984; 41: 710-718. (Pubitemid 14081386)
13. Davies SJC, Pandit SA, Feeney A, et al,. Is there cognitive impairment in clinically 'healthy' abstinent alcohol dependence? Alcohol Alcohol. 2005; 40: 498-503. (Pubitemid 41599999)
14. Fein G, Bachman L, Fisher S, Davenport L,. Cognitive impairments in abstinent alcoholics. West. Med. J. 1990; 152: 531-537. (Pubitemid 20153051)
15. Rourke S, Lobert T,. Neurobehavioral correlates of alcoholism. In:, Grant I, Adams K, (eds). Neuropsychological Assessment of Neuropsychiatric Disorders. Oxford University Press, New York, 1996; 423-485.
16. Mann K, Gunther A, Stetter R, Ackermann K,. Rapid recovery from cognitive deficits in abstinent alcoholics: A controlled test-retest study. Alcohol Alcohol. 1999; 34: 567-574. (Pubitemid 29371701)
17. Bohn MJ, Babor TF, Kranzler HR,. The Alcohol Use Disorders Identification Test (AUDIT): Validation of a screening instrument for use in medical settings. J. Stud. Alcohol 1995; 56: 423-432.
18. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM,. Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). Br. J. Addict. 1989; 84: 1353-1357. (Pubitemid 19281139)
19. Sobell LC, Sobell MB,. Timeline Follow-back: A technique for assessing self-reported alcohol consumption. In:, Litten RZ, Allen J, (eds). Measuring Alcohol Consumption: Psychosocial and Biological Methods. Humana Press, Towota, NJ, 1992; 41-72.
20. Nasreddine Z, Phillips NA, Bedirian V, et al,. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005; 53: 695-699. (Pubitemid 41623495)
21. Copersino ML, Fals-Stewar W, Fitzmaurice G, Schretlen DJ, Sokoloff J, Weiss RD,. Rapid cognitive screening of patients with substance use disorders. Exp. Clin. Psychopharmacol. 2009; 17: 337-344.
22. Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R, for the CAPSS-027 Study Group. Differential cognitive and behavioral effects of topiramate and valproate. Neurology 2003; 60: 1483-1488. (Pubitemid 36554811)
23. Loring DW, Williamson DJ, Meador KJ, Wiegand F, Hulihan J,. Topiramate dose effects on cognition: A randomized double-blind study. Neurology 2011; 76: 131-137.
24. American Psychiatric Association. American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders. Compendium 2006. American Psychiatric Association, Arlington, VA, 2006.
25. Zinn S, Bosworth HB, Edwards CL, Logue PE, Swartzwelder HS,. Performance of recently detoxified patients with alcoholism on a neuropsychological screening test. Addict. Behav. 2003; 28: 837-849. (Pubitemid 36638317)
26. Manning V, Wanigaratne S, Best D, et al,. Changes in neuropsychological functioning during alcohol detoxification. Eur. Addict. Res. 2008; 14: 226-233.